Adhera Therapeutics

(OTC) ATRX

Current Price$0.00

Market Cap$700

Since IPO (2016)-100%

5 Year-100%

1 Year+0%

1 Month+0%

Adhera Therapeutics Financials at a Glance

Market Cap

$700

Revenue (TTM)

$0.00

Net Income (TTM)

$4.49M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-294.22 (Low)

Dividend

$0.00

Beta (Volatility)

-294.22 (Low)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Dividend

$0.00

Beta (Volatility)

-294.22 (Low)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

ATRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Adhera Therapeutics

Industry

Biotechnology

Sector

Health Care

CEO

Zahed Subhan, PhD, MBA

Website

www.adherathera.com

Headquarters

Baton Rouge, LA 70820, US

ATRX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

-27%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$700.00

Shares Outstanding

7.22M

Volume

Avg. Volume

243.635

Financials (TTM)

Gross Profit

$0.00

Operating Income

$1.62M

EBITDA

$0.00

Operating Cash Flow

$1.42M

Capital Expenditure

$0.00

Free Cash Flow

$1.42M

Cash & ST Invst.

$32.00K

Total Debt

$8.59M

Adhera Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2023YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$700.00

N/A

Market Cap/Employee

$350.00

N/A

Employees

N/A

Net Income

$3.54M

-96.1%

EBITDA

$2.66M

-1548.7%

Quarterly Fundamentals

Name

Q3 2023YOY CHG

Net Cash

$10.80M

-37.4%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$10.09M

+26.2%

Return on Assets

-26.76%

N/A

Return on Invested Capital

7.29%

N/A

Free Cash Flow

$29.16K

+94.9%

Operating Cash Flow

$29.16K

+94.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CNNXFCannAmerica Brands Corp.

CNNXFCannAmerica Brands Corp.$0.00+0.00%

MOTSMotus GI Holdings, Inc.

MOTSMotus GI Holdings, Inc.$0.00+0.00%

PROTProteonomix, Inc.

PROTProteonomix, Inc.$0.00+0.00%

ONCSQOncoSec Medical Incorporated

ONCSQOncoSec Medical Incorporated$0.00+0.00%

GBIMGlobeImmune, Inc.

GBIMGlobeImmune, Inc.$0.00+0.00%

EFTReFFECTOR Therapeutics, Inc.

EFTReFFECTOR Therapeutics, Inc.$0.00-66.67%

CALACalithera Biosciences, Inc.

CALACalithera Biosciences, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$7.95+2.44%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.21+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.67-0.01%

XNDUXanadu Quantum Technologies

XNDUXanadu Quantum Technologies$13.94-0.61%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$45.35+0.02%

NOKNokia

NOKNokia$13.12-0.01%

GBTGGlobal Business Travel Group

GBTGGlobal Business Travel Group$9.34+0.58%

Questions About ATRX

What is the current price of Adhera Therapeutics?

Adhera Therapeutics is trading at $0.00 per share.

What is the 52-week range for Adhera Therapeutics?

Over the past 52 weeks, Adhera Therapeutics has traded between $0.00 and $0.01.

How much debt does Adhera Therapeutics have?

As of the most recent reporting period, Adhera Therapeutics reported total debt of $8.59M.

How much cash does Adhera Therapeutics have on hand?

Adhera Therapeutics reported $32,000 in cash and cash equivalents in its most recent financial results.

What is Adhera Therapeutics’s dividend yield?

Adhera Therapeutics does not currently have a dividend yield.

Adhera Therapeutics

Adhera Therapeutics Financials at a Glance

ATRX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Adhera Therapeutics

ATRX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Adhera Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ATRX

What is the current price of Adhera Therapeutics?

What is the 52-week range for Adhera Therapeutics?

How much debt does Adhera Therapeutics have?

How much cash does Adhera Therapeutics have on hand?

What is Adhera Therapeutics’s dividend yield?

Premium Investing Services